PubMed=2041050; DOI=10.1093/jnci/83.11.757
Anne Monks, Dominic A. Scudiero, Philip Skehan, Robert H. Shoemaker, Kenneth D. Paull, David T. Vistica, Curtis D. Hose, John Langley, Paul Cronise, Anne Vaigro-Wolff, Marcia Gray-Goodrich ...Show all 14 authors... , Hugh Campbell, Joseph G. Mayo, Michael R. Boyd; Show fewer authors
Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines.
J. Natl. Cancer Inst. 83:757-766(1991)

PubMed=7999427; DOI=10.1016/0959-8049(94)90188-0
Elaine S. Marshall, John H.L. Matthews, James H.F. Shaw, Johanna Nixon, Paul Tumewu, Graeme John Finlay, Karen M. Holdaway, Bruce Charles Baguley;
Radiosensitivity of new and established human melanoma cell lines: comparison of [3H]thymidine incorporation and soft agar clonogenic assays.
Eur. J. Cancer 30A:1370-1376(1994)

PubMed=7718330; DOI=10.1016/0959-8049(94)00472-H
Bruce Charles Baguley, Elaine S. Marshall, John Richard Whittaker, M.C. Dotchin, Johanna Nixon, Michael R. McCrystal, Graeme John Finlay, John H.L. Matthews, Karen M. Holdaway, Pierre Leonardus van Zijl;
Resistance mechanisms determining the in vitro sensitivity to paclitaxel of tumour cells cultured from patients with ovarian cancer.
Eur. J. Cancer 31A:230-237(1995)

PubMed=9488600; DOI=10.1007/s002800050744
Jian-Guo Ma, Marc Maliepaard, Kees Nooter, Antonius W.M. Boersma, Jaap Verweij, Gerrit Stoter, Jan H.M. Schellens;
Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitro.
Cancer Chemother. Pharmacol. 41:307-316(1998)